Asian equity markets traded mostly lower on Monday, weighed down by weaker U.S. stock futures, elevated Treasury yields, and ...
Analyst rates Kura Oncology a Sell: $5.85 fair value is below $7.43; about $72 million in quarterly burn could leave net cash ...
Johnson & Johnson is in talks to buy Ollin Biosciences for up to $3.4B, including $2.2B upfront and $1.2B in potential ...
Increases in the first half of November included Emerson’s 7.2% boost for its 70th year of growth; ADP, ConocoPhillips, ...
Sociedad Química y Minera de Chile is a Buy: the recent selloff offers a long-term lithium opportunity despite a rocky ...
I maintain a "Buy" rating on DiaMedica Therapeutics, supported by DM199 catalysts across stroke, preeclampsia, and fetal ...
Analyst rates Fortinet a Buy: 2026 guidance calls for 28% billings growth at midpoint and 13% service revenue growth, ...
Analyst rates Albertsons a Strong Buy, with shares that could offer 53.6%-336.8% upside if valued at peer multiples.
The bear case on IonQ: valuation still looks aggressive after a 60% fall from its 52-week high; stock-funded deals nearly ...
BlackRock Utilities Infrastructure & Power Opportunities Trust remains a Buy: its below-average price-to-NAV valuation and AI ...
EBITDA guidance rose on a reporting change, not stronger fundamentals; free cash flow is -$455 million amid tax ...
Analyst rates Flutter Entertainment a Hold: at $81.70, shares offer limited upside to an $84.50 target amid FanDuel share ...